Position in ABBV
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$61,726,054
+$16,749,626 QoQ
Shares Held
283,811
+44.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $451,805,560 across 10 Drug Manufacturers - General names. ABBV ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
127,233 | $117,025,096 | |
| 2 | JNJ |
Johnson & Johnson
|
397,877 | $97,257,053 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
283,811 | $61,726,054 | |
| 4 | AZN |
Astrazeneca PLC
|
236,302 | $46,603,480 | |
| 5 | MRK |
Merck & Co., Inc.
|
364,485 | $43,843,900 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
222,601 | $31,023,901 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
332,662 | $20,175,950 | |
| 8 | AMGN |
Amgen Inc
|
50,366 | $17,721,277 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,726,054 | 283,811 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $44,976,428 | 196,842 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $24,844,242 | 107,300 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,884,376 | 74,800 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $15,169,248 | 72,400 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $27,952,210 | 157,300 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $34,085,048 | 172,600 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $39,569,664 | 230,700 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $51,297,570 | 281,700 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $20,208,088 | 130,400 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $7,512,624 | 50,400 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,595,774 | 63,800 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,996,530 | 69,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,068,303 | 62,300 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,213,110 | 91,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,642,096 | 95,600 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $15,543,920 | 114,800 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $8,996,358 | 83,400 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $11,070,906 | 102,300 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,000,800 | 112,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $10,756,052 | 122,800 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,046,686 | 122,700 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $7,626,619 | 100,100 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||